Fundraising Fox2Flo Ventures — Full Portfolio
9 tracked investments · listed companies and verified rows first
Vivacelle Bio develops phospholipid nanoparticle therapies (VBI-S and VBI-1) that restore intravascular volume and redirect excess nitric oxide to treat hypovolemia in patients with septic shock or severe blood loss.
BiotechHealthtechMedical DevicesChicago, US
Cuthbert Ormand Simpkins(Executive Officer, Director)Diane Simpkins(Co-Founder & Treasurer, Board of Directors)inConrad Epting(Founding Member / Scientific Consultant)inHarven DeShield(Executive Officer, Director)inPaul(CEO/CFO)Stephen N. Keith(Former CEO)in
4D Healthware offers Virtual CCM, a technology platform for chronic care management that lets healthcare providers deliver care beyond the clinic in settings such as homes, pharmacies, grocery stores, workplaces, and online.
AI & Machine LearningDigital HealthHealthtechSaaSChicago, US
Star Cunningham(Founder)in
Co-investorsPortfolia
AKAN Biosciences is a biotechnology and cellular therapy company developing injectable, adipose stem cell-based regenerative products to treat degenerative diseases and injuries.
BiotechHealthtechMedical Devices
CancerIQ is a healthcare software platform that helps hospitals and providers run cancer risk-assessment and precision prevention programs by gathering patient data, triaging patients into risk tiers using guidelines like NCCN and Tyrer-Cuzick, and managing genetic counseling, testing, and ongoing care.
Digital HealthHealthtechSaaSChicago, US
Olufeyikemi Olopade Ayodele(Executive Officer, Director)Feyi Ayodele(Founder)inHaibo Lu(Executive Officer, Director)Christopher Bun(Executive Officer)Jordan Dolin(Director)Evan Wood(Director)
Co-investorsCleveland AvenueHealthX VenturesLightbankMcKesson VenturesMerck Global Health Innovation FundMSD Global Health Innovation Fund+2 more
Delphian Tx is a clinical-stage biopharmaceutical company developing cannabinoid-based drugs (CBD:THC combinations) targeting the endocannabinoid system to treat migraine and other complex pain and CNS disorders.
BiotechHealthtech
KeyCare builds virtual care technology and telehealth solutions to extend health system capacity and improve access to healthcare.
Digital HealthEnterprise SoftwareHealthtechSaaSChicago, US
Lyle Berkowitz(Founder)inSulabh Agarwal(Executive Officer, Director)inCarrie Nelson, MDinMike Robbins(Executive Officer)inAndy JacksoninJennifer Timmin
Co-investors8VCBold Capital PartnersCorewell Health VenturesHealthX VenturesMarram VenturesCultivation Capital+1 more
ResQ Pharma is a pharmaceutical company developing LipidRescue (LRT), an investigational lipid-based drug therapy that is pending FDA approval.
BiotechHealthtechGlenview, US
Guy Weinberg(Director, President and Secretary of Issuer)inDr. Weinberg(Founder and President)inAugust H. Schupp(Director, CAO and General Counsel of Issuer)Dominic O'Keefe(Director and COO of Issuer)David Bowman(Executive Officer)Dr. Mukesh Kumar(Director of Regulatory Affairs)in
Temprian Oncology develops nanoparticle-based "Supercarriers" that deliver a prodrug toxic to melanoma cells, releasing the active ingredient inside metastatic melanoma tumor cells in low-pH pigment-making organelles.
BiotechDeep TechHealthtech
Temprian Therapeutics is a biopharmaceutical company developing an HSP70i-based immunotherapy for vitiligo.
BiotechDigital HealthHealthtechChicago, US
Isabelle Caroline Le Poole(Executive Officer, Director)Caroline Le Poole(CSO & Co-Founder)inSumeet Dagar(CEO)inPaul Burton(CFO & Board Member)inJohn Nieland(Chief Innovation Officer)inKettil Cedercreutz(Board Member & Co-Founder)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.